Intelligent Investment
Greater Tokyo Market
Global Life Sciences Atlas
April 11, 2025 5 Minute Read

Overview
- Greater Tokyo offers Japan’s most comprehensive life sciences industry presence from research and development (R&D) to front office and headquarters locations.
- Greater Osaka also offer a significant Japanese life sciences industry presence, but not to the same degree as Greater Tokyo.
- Strong growth in Japanese R&D expenditures in recent years has coincided with growing interest in leasable lab spaces, as more companies look to restructure their R&D facilities/systems to allow for more collaboration with other companies/institutes as well as to enhance staffing.
Submarkets
- Total leasable space of wet labs in the Greater Tokyo Area is estimated to be 134,000 tsubo (c. 4.8 million sq.ft.), many of which are concentrated in Yokoyama and Kawasaki.
- New construction lab rents, Tokyo CBD $49-$54.
Figure 1: Number of Life Science Related Researchers in Japan
Figure 2: Leasable space of wet labs in Greater Tokyo (‘000 tsubo)
Life Sciences Venture Capital Investment Trends
Figure 3: Greater Tokyo Life Sciences Venture Capital Funding
Life Sciences Market Stats
Figure 4: Leasable space of wet labs by City (‘000 tsubo)
- Astellas Pharma Inc.
- Chugai Pharmaceutical Co., Ltd.
- Daiichi Sankyo, Inc.
- Eisai Co., Ltd.
- Fujifilm Holdings Corp.
- Kyowa Kirin Co., Ltd.
- Ono Pharmaceutical Co., Ltd.
- Otsuka Pharmaceutical Co., Ltd.
- Shionogi & Co., Ltd.
- Sumitomo Pharma Co., Ltd.
- Takeda Therapeutics